Literature DB >> 6088580

Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons.

M E Wheeler, A C Cox, R C Carroll.   

Abstract

To investigate the association of the putative platelet fibrinogen receptor (glycoprotein IIb-III(a) with the cytoskeleton, 125I-surface labeled human platelets washed by gel-filtration were activated under conditions which allow selective assembly of the platelet cytoskeleton. The four conditions were activation with arachidonate or phorbol 12-myristate 13-acetate (PMA) with and without pretreatment with cytochalasin E. Activation with arachidonate generates a complete cytoskeletal core (pseudopodal and contractile elements) while PMA activation forms only an actin plus actin-binding protein pseudopodal core. Pretreatment with cytochalasin E leads to actomyosin contractile core formation if arachidonate activated, and essentially blocks cytoskeletal development if PMA activated. Cytoskeletal cores from arachidonate or PMA-activated platelets retained 26 (+/- 3%) of the total 125I-IIIa. Pretreatment with cytochalasin E followed by arachidonate or PMA activation reduced the 125I-IIIa retention to near control levels (unactivated platelets: 4 +/- 2%). The role of aggregation vs. receptor occupancy in the retention of IIb-IIIa was assessed by activation of platelets with arachidonate in the presence of fibrinogen fragment D (0.6-12 mg/ml). Aggregation was blocked by increasing concentrations of fragment D reagent while cytoskeletal assembly was not altered. The IIIa retention correlated with extent of aggregation with maximal retention corresponding to full aggregation. To determine if cytoskeletal development is necessary for the expression of the fibrinogen binding site, binding studies were performed with unlabeled platelets and 125I-fibrinogen. The mean number of binding sites and the mean dissociation constant were not significantly different among the four activation conditions. Although the development of a platelet cytoskeletal core is not required for the expression of the fibrinogen binding site, the retention of the glycoprotein IIb-IIIa complex is dependent on fibrinogen-supported aggregation as well as the formation of the pseudopodal cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088580      PMCID: PMC425267          DOI: 10.1172/JCI111475

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Human platelets possess an inducible and saturable receptor specific for fibrinogen.

Authors:  G A Marguerie; E F Plow; T S Edgington
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

2.  Cytochalasin B and the structure of actin gels.

Authors:  J H Hartwig; T P Stossel
Journal:  J Mol Biol       Date:  1979-11-05       Impact factor: 5.469

3.  On the biochemistry of transformation by Rous sarcoma virus.

Authors:  S J Singer; J F Ash; R C Carroll; M H Heggeness; P K Vogt
Journal:  Prog Clin Biol Res       Date:  1980

4.  Localization of human platelet membrane-associated actomyosin using the affinity label 5'-p-fluorosulfonylbenzoyl adenosine.

Authors:  J S Bennett; G Vilaire; R F Colman; R W Colman
Journal:  J Biol Chem       Date:  1981-02-10       Impact factor: 5.157

5.  Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin.

Authors:  J F Mustard; R L Kinlough-Rathbone; M A Packham; D W Perry; E J Harfenist; K R Pai
Journal:  Blood       Date:  1979-11       Impact factor: 22.113

6.  Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.

Authors:  E I Peerschke; M B Zucker
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249

7.  Correlation between fibrinogen binding to human platelets and platelet aggregability.

Authors:  E I Peerschke; M B Zucker; R A Grant; J J Egan; M M Johnson
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

8.  Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome.

Authors:  I Hagen; A Nurden; O J Bjerrum; N O Solum; J Caen
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

9.  Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules.

Authors:  J M Gerrard; D R Phillips; G H Rao; E F Plow; D A Walz; R Ross; L A Harker; J G White
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  Identification of membrane proteins mediating the interaction of human platelets.

Authors:  D R Phillips; L K Jennings; H H Edwards
Journal:  J Cell Biol       Date:  1980-07       Impact factor: 10.539

View more
  10 in total

1.  Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.

Authors:  S R Hanson; F I Pareti; Z M Ruggeri; U M Marzec; T J Kunicki; R R Montgomery; T S Zimmerman; L A Harker
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Identification and isolation of a platelet GPIb-like protein in human umbilical vein endothelial cells and bovine aortic smooth muscle cells.

Authors:  A S Asch; B Adelman; M Fujimoto; R L Nachman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase.

Authors:  E Kornecki; Y H Ehrlich; D D De Mars; R H Lenox
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.

Authors:  R Wang; S J Shattil; D R Ambruso; P J Newman
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.

Authors:  M Torti; G Ramaschi; F Sinigaglia; E G Lapetina; C Balduini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.

Authors:  E Kloprogge; P Hasselaar; J W Akkerman
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

7.  Translocation of pp60c-src to the cytoskeleton during platelet aggregation.

Authors:  A R Horvath; L Muszbek; S Kellie
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

8.  Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution.

Authors:  P J Newman; C A Hillery; R Albrecht; L V Parise; M C Berndt; A V Mazurov; L C Dunlop; J Zhang; S E Rittenhouse
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

9.  Reciprocal transmembranous receptor-cytoskeleton interactions in concanavalin A-activated platelets.

Authors:  M E Wheeler; J M Gerrard; R C Carroll
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

10.  Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets.

Authors:  M E Bertagnolli; M C Beckerle
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.